The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
Prevention and choice of therapeutic strategies in patient,s with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development from early stages of T2D. Glucose-lowering and cardiac medications for the prevention and treatment...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2019-11-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3581 |
_version_ | 1797856772101242880 |
---|---|
author | Zh. D. Kobalava V. V. Medovchshikov N. B. Yeshniyazov E. R. Khasanova |
author_facet | Zh. D. Kobalava V. V. Medovchshikov N. B. Yeshniyazov E. R. Khasanova |
author_sort | Zh. D. Kobalava |
collection | DOAJ |
description | Prevention and choice of therapeutic strategies in patient,s with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development from early stages of T2D. Glucose-lowering and cardiac medications for the prevention and treatment of HF depending on its phenotypes were considered. |
first_indexed | 2024-04-09T20:45:59Z |
format | Article |
id | doaj.art-bd265992d55c487299c6d6e34d3cde83 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2024-04-09T20:45:59Z |
publishDate | 2019-11-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-bd265992d55c487299c6d6e34d3cde832023-03-29T21:23:34Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202019-11-010119811110.15829/1560-4071-2019-11-98-1112784The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitusZh. D. Kobalava0V. V. Medovchshikov1N. B. Yeshniyazov2E. R. Khasanova3Peoples' Friendship University of Russia (RUDN University); Vinogradov City HospitalPeoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University)Prevention and choice of therapeutic strategies in patient,s with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development from early stages of T2D. Glucose-lowering and cardiac medications for the prevention and treatment of HF depending on its phenotypes were considered.https://russjcardiol.elpub.ru/jour/article/view/3581diabetesheart failuresubclinical myocardial dysfunctiondiabetic cardiomyopathydiabetic nephropathypreserved ejection fractionpathophysiologysglt2 inhibitors |
spellingShingle | Zh. D. Kobalava V. V. Medovchshikov N. B. Yeshniyazov E. R. Khasanova The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus Российский кардиологический журнал diabetes heart failure subclinical myocardial dysfunction diabetic cardiomyopathy diabetic nephropathy preserved ejection fraction pathophysiology sglt2 inhibitors |
title | The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus |
title_full | The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus |
title_fullStr | The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus |
title_full_unstemmed | The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus |
title_short | The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus |
title_sort | modern paradigm of pathophysiology prevention and treatment of heart failure in type 2 diabetes mellitus |
topic | diabetes heart failure subclinical myocardial dysfunction diabetic cardiomyopathy diabetic nephropathy preserved ejection fraction pathophysiology sglt2 inhibitors |
url | https://russjcardiol.elpub.ru/jour/article/view/3581 |
work_keys_str_mv | AT zhdkobalava themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT vvmedovchshikov themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT nbyeshniyazov themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT erkhasanova themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT zhdkobalava modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT vvmedovchshikov modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT nbyeshniyazov modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus AT erkhasanova modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus |